Status:
COMPLETED
Monitoring Vital Signs With a Wireless Ingestible Device in Subjects Undergoing Polysomnography
Lead Sponsor:
Celero Systems, Inc.
Conditions:
Sleep
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This Minimal Risk study is designed to evaluate the ability of the Celero ingestible Vitals Monitoring Pill (i.e., VM Pill) to measure respiration from within the gastrointestinal tract, in addition t...
Eligibility Criteria
Inclusion
- Healthy individuals ages 18 - 65 inclusive who are indicated for a polysomnography study.
Exclusion
- Patients with a history of abdominal surgery and/or any condition that may impact the GI tract, including but not limited to:
- Constipation
- Esophageal stricture
- Esophagitis
- Gastritis
- Gastric ulcers
- Peptic ulcer
- Gallstones
- Celiac Disease
- Crohn's Disease
- Ulcerative Colitis
- Irritable Bowel Syndrome
- Diverticulitis
- Colorectal cancer
Key Trial Info
Start Date :
December 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05183529
Start Date
December 14 2021
End Date
October 31 2023
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West Virginia University
Morgantown, West Virginia, United States, 26506